Cash from Operations (Quarterly) Chart

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2011. Start Trial.
Date Value
March 31, 2026 -0.16M
December 31, 2025 -0.246M
September 30, 2025 -0.106M
June 30, 2025 -0.059M
March 31, 2025 -0.057M
December 31, 2024 0.026M
September 30, 2024 0.00
June 30, 2024 0.015M
March 31, 2024 -0.045M
December 31, 2023 -0.051M
September 30, 2023 -0.051M
June 30, 2023 -0.032M
March 31, 2023 -0.065M
December 31, 2022 -0.125M
September 30, 2022 -0.129M
June 30, 2022 -0.152M
March 31, 2022 -0.161M
December 31, 2021 -0.1603M
September 30, 2021 -0.2038M
June 30, 2021 -0.137M
March 31, 2021 -0.0809M
December 31, 2020 -0.0826M
September 30, 2020 -0.1406M
June 30, 2020 -0.2544M
March 31, 2020 -0.2185M
Date Value
December 31, 2019 -0.233M
September 30, 2019 -0.3454M
June 30, 2019 -0.3704M
March 31, 2019 -0.3196M
December 31, 2018 -0.5773M
September 30, 2018 -0.7625M
June 30, 2018 -0.5052M
March 31, 2018 -0.5415M
December 31, 2017 -0.4048M
September 30, 2017 -0.2901M
June 30, 2017 -0.3277M
March 31, 2017 -0.4478M
December 31, 2016 -0.4025M
September 30, 2016 -0.3118M
June 30, 2016 -0.3093M
March 31, 2016 -0.2666M
December 31, 2015 -0.2967M
September 30, 2015 0.4491M
June 30, 2015 -0.3197M
March 31, 2015 -0.3067M
December 31, 2014 -0.0588M
September 30, 2014 -0.3314M
June 30, 2014 -0.24M
March 31, 2014 -1.176M
December 31, 2013 -0.2703M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
BioForce Nanosciences Holdings, Inc. -0.027M
Skinhealth Systems, Inc. 2.671M
CCA Industries, Inc. -0.3804M
Cyanotech Corp. 0.423M
The Estée Lauder Companies, Inc. 576.00M